|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans (RPW, KR, and JH); the Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (DG and XD); the Department of Medicine, Tulane University School of Medicine, New Orleans (JH); and the Tulane Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans (JH)
2 This study was funded by a contractual agreement between Tulane University and Pfizer Inc. The analysis and interpretation of the data were supported in part by the National Institutes of Health (grant number 1 K12 HD43451-01 to RPW). JH received support from the National Heart, Lung and Blood Institute/National Institutes of Health (grants HL68057 and HL72507). 3 Address reprint requests to RP Wildman, Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2000, SL-18, New Orleans, LA 70112. E-mail: rwildman{at}tulane.edu.
| ABSTRACT |
|---|
|
|
|---|
Objective: We aimed to identify cutoffs for body mass index (BMI; in kg/m2) and waist circumference that confer increased risk of cardiovascular disease in Chinese adults as would be consistent with overweight and central adiposity.
Design: A nationally representative, cross-sectional sample of 15 239 Chinese adults aged 3574 y was studied.
Results: Mean blood pressure, total cholesterol, LDL-cholesterol, triacylglycerol, and glucose values were incrementally higher and mean HDL-cholesterol values were incrementally lower with each unit increase in BMI and waist circumference in both men and women. Both the point at which sensitivity equaled specificity and the shortest distance in the receiver operating characteristic curves for hypertension, dyslipidemia, diabetes, or
2 of these risk factors suggested a BMI cutoff of 24 and a waist circumference cutoff of 80 cm for both men and women.
Conclusions: Lower cutoffs for BMI and waist circumference are needed in the identification of Chinese patients at high risk of cardiovascular disease.
Key Words: Obesity China body mass index waist circumference cardiovascular disease risk factors cutoffs
| INTRODUCTION |
|---|
|
|
|---|
The current definitions of overweight [body mass index (BMI, in kg/m2)
25] and central adiposity (waist circumference
94 cm for men and
80 cm for women) recommended by the World Health Organization (WHO; 7) are based on data from Western populations. However, a growing body of literature indicates that these cutoffs likely need to be lower among Asian populations and may not even be appropriate among Western populations in the United States and Europe (8, 9). Several epidemiologic studies in Asian populations have shown that Asians have higher amounts of body fat at lower BMIs and waist circumferences than do Western populations (10-12), perhaps leading to the greater prevalence of cardiovascular disease risk factors at lower BMIs in Asian populations than in Western populations (13-16).
In response to these findings, the Western Pacific regional office of the WHO, the International Association for the Study of Obesity (IASO), and the International Obesity Task Force (IOTF) collaborated in the creation of new recommendations for BMI and waist circumference cutoffs among Asian populations, labeling these recommendations as provisional and calling for their validation by additional clinical and epidemiologic study (17). In these recommendations, overweight is defined as a BMI
23, and the suggested waist circumference cutoffs are 90 cm for men and 80 cm for women (17). These recommendations are based on a limited literature concerning the distribution of BMI and waist circumference measures in Asian populations and the associations between these measures and the prevalence of cardiovascular disease risk factors or risk of cardiovascular disease. The purpose of the present study was 2-fold: 1) to identify cutoffs for BMI and waist circumference that confer increased risk of cardiovascular disease in Chinese adults as would be consistent with overweight and central adiposity, and 2) to compare our findings with the cutoffs identified in the WHO/IASO/IOTF recommendations.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
A total of 19 012 individuals were randomly selected from 20 primary sampling units (street districts in urban areas or townships in rural areas) and invited to participate. A total of 15 838 individuals completed the survey and examination, a response rate of 83.3% (82.1% in men and 84.5% in women; 82.2% in urban areas and 84.4% in rural areas).
The Institutional Review Board at Tulane University Health Sciences Center approved the InterASIA study. In addition, ethics committees and other relevant regulatory bodies in China approved the study. Informed consent was obtained from each participant before data collection.
Anthropometric measurements
Data collection involved one visit to 1 of 20 examination centers at local health stations or in community clinics in the participants' residential areas. During the examinations, a standard questionnaire assessing demographic information and medical history was administered by trained research staff.
Anthropometric measures were taken according to a standard protocol by observers trained by an investigator from the United States (JH). Body weight was measured while the subjects were without clothes or shoes by using a double balance placed on a firm surface; balances at all 20 examination centers were identical and were calibrated with a standard InterASIA protocol. Height was measured by using a Frankfort place positioned at a 90° angle against a wall-mounted metal tape. Waist circumference was measured with a standard tape measure on bare skin, 1 cm above the naval; identical tape measures were used at all examination centers. BMI was calculated as weight in kg divided by height in m2.
Blood pressure measurement
Three blood pressure measurements were obtained by trained nurses and physicians according to a standard protocol adapted from American Heart Association recommendations; the measurements were made with the participant in a sitting position after
5 min of rest (19). A standard mercury sphygmomanometer was used with 1 of 4 cuff sizes (pediatric, regular adult, large adult, or thigh). The participants were advised to refrain from coffee, tea, or alcohol intake; cigarette smoking; and vigorous exercise for
30 min before their examination. All study investigators and staff members successfully completed a training program orienting them to both the aims of the study and the specific tools and methods used.
Hypertension was defined as self-reported use of antihypertensive medication within the past 2 wk or an average systolic blood pressure
140 mm Hg, an average diastolic blood pressure
90 mm Hg, or both.
Laboratory methods
After the subjects had fasted overnight, blood samples were drawn by venipuncture to measure serum total cholesterol, HDL cholesterol, triacylglycerols, and glucose. Blood specimens were processed at the field center, were stored at 70 °C, and were shipped by air monthly to the central clinical laboratory at the Department of Population Genetics at Fuwai Hospital of the Chinese Academy of Medical Sciences in Beijing. Here the specimens were again stored at 70 °C until laboratory assays could be performed. This laboratory participates in the Lipid Standardization Program of the US Centers for Disease Control and Prevention.
Total cholesterol, HDL cholesterol, and triacylglycerols were analyzed enzymatically on a Hitachi 7060 clinical analyzer (Hitachi High-Technologies Corporation, Tokyo) by using commercial reagents (20). LDL-cholesterol concentrations were calculated by using the Friedewald equation for the participants who had triacylglycerol concentrations < 400 mg/dL: LDL cholesterol = total cholesterol -HDL cholesterol -triacylglycerols/5 (21). Dyslipidemia was defined as either total cholesterol
200 mg/dL, LDL cholesterol
130 mg/dL, or HDL cholesterol < 35 mg/dL. The same HDL cutoff was used for both men and women because of similar HDL-cholesterol concentrations between men and women in China (22). Plasma glucose was measured by using a modified hexokinase enzymatic method. Diabetes was defined as fasting plasma glucose
126 mg/dL, use of insulin or oral hypoglycemic agents, or a self-reported history of diabetes.
Statistical methods
Of the 15 838 participants who completed the InterASIA examination and survey, the following were excluded from the current analyses: 298 for being outside of the 3574-y age range, 281 for missing laboratory data, and 21 for missing BMI or waist circumference data. Therefore, data from 15 238 participants were used in the current analyses.
The mean and prevalence of cardiovascular disease risk factors were weighted to represent the total Chinese population aged 3574 y. Weights were calculated based on the 2000 China population census data and took into account several features of the survey, including oversampling for specific age or geographic subgroups, nonresponse, and other demographic or geographic differences between the sample and the total Chinese population. Standard errors were calculated to take into account the stratified sampling design and the weights resulting from the complex survey design. Age-standardization was performed by the direct method by using the 2000 China population aged 3574 y as the standard population. The sensitivity and specificity of each BMI and waist circumference level for the detection of hypertension, dyslipidemia, diabetes, and 2 or more of these risk factors were calculated by creating dichotomous variables for each BMI and waist circumference value (eg, BMI < 22 versus BMI
22). Additionally, the distance on the receiver operating characteristic (ROC) curve of each BMI and waist circumference value was calculated as the square root of [(1 sensitivity)2 + (1 specificity)2]. The BMI or waist circumference value with the shortest distance on the ROC curve was considered in the determination of appropriate cutoffs. All data analyses were conducted by using SUDAAN (version 8.0; Research Triangle Institute, Research Triangle Park, NC).
| RESULTS |
|---|
|
|
|---|
|
|
29, in large part because of the persons with
2 risk factors.
|
2 of these risk factors are presented in Table 3
2 risk factors was at a BMI of 24 for men and women.
|
|
|
95 cm, in large part because of the persons with
2 risk factors.
|
2 of these risk factors are presented in Table 6
|
| DISCUSSION |
|---|
|
|
|---|
Despite low BMIs and waist circumferences in China, cardiovascular disease is now the leading cause of death in China, with mortality projected to increase over the next decade (23, 24). In the current study, mean values of cardiovascular disease risk factors and prevalences of hypertension, dyslipidemia, and diabetes were higher with each successively higher BMI and waist circumference level. These data agree with other studies in Chinese and other Asian populations documenting linear relations between BMI or waist circumference and cardiovascular disease risk factors (13, 25-27). Evidence shows that Asian populations have a higher percentage of body fat than do Western populations for a given BMI or waist circumference (10-12, 28, 29). This may be partially responsible for the greater prevalence of cardiovascular disease risk factors at low BMI and waist circumference values as shown by the present study and others (13-16). These findings strongly corroborate the need for Asian-specific cutoffs of BMI and waist circumference as called for by the report of the joint WHO/IASO/IOTF committee.
Since the joint WHO/IASO/IOTF committee report, several studies have examined appropriate cutoffs for overweight in Asian populations (13, 14, 16, 26, 27, 30). The cutoffs proposed to define overweight and central adiposity have been lower than those established in the original WHO recommendations, with the exception of waist circumference for women (7), and have also been lower than those recommended by the joint WHO/IASO/IOTF committee for central adiposity (90 cm for men and 80 cm for women) (17). Most studies have suggested a BMI cutoff of 2224 for men and women and a waist circumference cutoff near 7580 cm for women and 8085 cm for men (13, 14, 16, 25-27, 30). The present study is the first to examine appropriate BMI and waist circumference cutoffs in a representative sample of the general adult Chinese population and suggests cutoffs similar to those reported in other studies of Asian populations.
Efficient clinical practice requires guidelines for the identification of individuals who should be targeted for monitoring, prevention, and possible treatment. The cutoffs recommended here were identified as the values of BMI and waist circumference that best balanced sensitivity and specificity. This decision rule accommodates the desire to prevent a significant proportion of cardiovascular disease events, the clinical practice burden of population-wide prevention and treatment efforts, and the patient burden of being labeled as being at increased risk of cardiovascular disease. Given the continuous increase in prevalence of cardiovascular disease risk factors with increasing BMI and waist circumference shown by the present data, it must be acknowledged that all cutoffs are arbitrary; no threshold in BMI or waist circumference can be determined whereby values below the threshold confer no increased risk of cardiovascular disease and values above confer a uniform increased risk. We encourage the use of these data by a collaboration of public health agencies and health professionals in China and other Asian countries who can first decide on the collective tolerance of false positives and false negatives that should correspond to official overweight and central adiposity definitions.
The slight differences in suggested values between all of the studies that have sought to determine Asian-specific clinical cutoffs for BMI and waist circumference may reflect different decision rules regarding the acceptable relative amounts of over- and underpresumption of cardiovascular disease risk. Alternatively, they may represent underlying differences in the body fat percentage corresponding to a given BMI or waist circumference value between Asians of different ethnic backgrounds (28). Whether it is appropriate to apply the same BMI and waist circumference cutoffs to all Asian populations needs to be addressed further.
The present study has several strengths. This was a representative sample of the general adult Chinese population. Thus, these results can be generalized to the full adult population of mainland China aged 3574 y. Additionally, we provided data for a wide range of BMI and waist circumference values, stratified by sex, to enable the use of these data by Asian public health officials for the development of BMI and waist circumference definitions based on decision rules that may differ from those we applied. These data are cross-sectional, however. One meta-analysis utilizing prospective data confirmed the need for a lower cutoff among Chinese adults, but this was not based on a nationally representative sample (31). However, prospective studies assessing all-cause mortality have not shown a need for lower cutoffs in Asians; relative risk of mortality was increased only for those in the highest BMI categories (BMI of 3039.9; 32). Future studies in a representative sample of the adult Chinese population that prospectively relate the BMI and waist circumference cutoffs suggested here to the incidence of hypertension, dyslipidemia, diabetes, clinical cardiovascular disease events, cardiovascular disease mortality, and all-cause mortality are needed. To adequately address inconsistencies in the literature, these future studies will need to examine Asian and Western populations together, enabling direct comparisons (33). These future studies will also need to examine the suggested cutoffs on the basis of both relative risk of cardiovascular disease and sensitivity-specificity. The present study did not have direct measures of body fatness or fat distribution. Because BMI and waist circumference are supposed surrogates for body fatness and fat distribution, future research is needed into racial-ethnic differences in the relations between BMI, waist circumference, and actual body fatness and body fat distribution.
The high prevalences of hypertension, dyslipidemia, and diabetes at low BMI and waist circumference values shown here among Chinese adults strongly argue for lower Asian-specific BMI and waist circumference cutoffs for use in clinical practice. These data show a BMI value of 24 and a waist circumference value of 80 cm in both men and women as appropriate for use in the identification of high-risk Chinese patients. The continuous relation between cardiovascular disease risk factors and BMI and waist circumference documented here, together with the increasing incidence of cardiovascular disease morbidity and mortality in China, underscore the importance that Chinese health care professionals are given an appropriate definition of overweight for immediate use in screening.
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. T Tuan, L. S Adair, C. M Suchindran, K. He, and B. M Popkin The association between body mass index and hypertension is different between East and Southeast Asians Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1905 - 1912. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Tuan, L. S. Adair, K. He, and B. M. Popkin Optimal Cutoff Values for Overweight: Using Body Mass Index to Predict Incidence of Hypertension in 18- to 65-Year-Old Chinese Adults J. Nutr., July 1, 2008; 138(7): 1377 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stevens, K. P. Truesdale, E. G. Katz, and J. Cai Impact of Body Mass Index on Incident Hypertension and Diabetes in Chinese Asians, American Whites, and American Blacks: The People's Republic of China Study and the Atherosclerosis Risk in Communities Study Am. J. Epidemiol., June 1, 2008; 167(11): 1365 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A Lear, K. H Humphries, S. Kohli, A. Chockalingam, J. J Frohlich, and C L. Birmingham Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT) Am. J. Clinical Nutrition, August 1, 2007; 86(2): 353 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. McLaren, L. M. Ghali, D. Lorenzetti, and M. Rock Out of context? Translating evidence from the North Karelia project over place and time Health Educ. Res., June 1, 2007; 22(3): 414 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gu, J. He, X. Duan, K. Reynolds, X. Wu, J. Chen, G. Huang, C.-S. Chen, and P. K. Whelton Body Weight and Mortality Among Men and Women in China JAMA, February 15, 2006; 295(7): 776 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Snijder, R. van Dam, M Visser, and J. Seidell What aspects of body fat are particularly hazardous and how do we measure them? Int. J. Epidemiol., February 1, 2006; 35(1): 83 - 92. [Full Text] [PDF] |
||||
![]() |
D. L. Bhatt, P. G. Steg, E. M. Ohman, A. T. Hirsch, Y. Ikeda, J.-L. Mas, S. Goto, C.-S. Liau, A. J. Richard, J. Rother, et al. International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis JAMA, January 11, 2006; 295(2): 180 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P Wildman, D. Gu, K. Reynolds, X. Duan, X. Wu, and J. He Are waist circumference and body mass index independently associated with cardiovascular disease risk in Chinese adults? Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1195 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raman, R. J. Colman, Y. Cheng, J. W. Kemnitz, S. T. Baum, R. Weindruch, and D. A. Schoeller Reference Body Composition in Adult Rhesus Monkeys: Glucoregulatory and Anthropometric Indices J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2005; 60(12): 1518 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Levantesi, A. Macchia, R. Marfisi, M. G. Franzosi, A. P. Maggioni, G. L. Nicolosi, C. Schweiger, L. Tavazzi, G. Tognoni, F. Valagussa, et al. Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial Infarction J. Am. Coll. Cardiol., July 19, 2005; 46(2): 277 - 283. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |